| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 1.721 | 6.765 | 24.715 | 69.597 | 66.312 | 100.443 |
| Total Income - EUR | - | - | - | - | 1.721 | 6.765 | 24.715 | 69.597 | 66.312 | 100.443 |
| Total Expenses - EUR | - | - | - | - | 0 | 0 | 2.032 | 9.525 | 21.370 | 45.523 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.721 | 6.765 | 22.683 | 60.072 | 44.942 | 54.920 |
| Net Profit/Loss - EUR | - | - | - | - | 1.670 | 6.562 | 21.980 | 58.318 | 44.313 | 52.512 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Botezan Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 5.965 | 8.317 | 83.443 |
| Current Assets | - | - | - | - | 1.721 | 8.454 | 30.593 | 77.474 | 141.294 | 155.872 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 1.384 | 7.884 | 14.967 | 35.738 | 64.811 | 42.169 |
| Cash | - | - | - | - | 337 | 570 | 15.626 | 41.735 | 76.483 | 113.703 |
| Shareholders Funds | - | - | - | - | 1.670 | 8.201 | 29.999 | 82.935 | 126.996 | 148.643 |
| Social Capital | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Debts | - | - | - | - | 52 | 254 | 595 | 503 | 22.615 | 118.581 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Botezan Medica S.r.l.